期刊文献+

肝素抗凝血浆和血清的肝纤维化标志物检测结果比较 被引量:10

Comparison of the test results of heparinized plasma and serum hepatic fibrosis markers
下载PDF
导出
摘要 目的对比观察血浆和血清中Ⅳ型胶原(CIV)、透明质酸(HA)、Ⅲ型前胶原(PCⅢ)和层黏蛋白(LN)的测定结果。方法采用放射免疫法对56例健康人的血清与肝素抗凝血浆进行肝纤维化4项标志物测定,并对检测结果进行比较。结果血清中CIV、PCⅢ、LN含量大于血浆中的含量,差异有统计学意义(P<0.05);血浆中HA含量则大于血清中的含量,差异也有统计学意义(P<0.05)。血浆CIV、HA、PCⅢ含量与血清含量存在相关关系(P<0.001);而LN含量不存在相关关系,差异无统计学意义(P>0.05)。结论血浆可测定肝纤维化4项标志物,且3项标志物与血清存在相关关系。由于其CIV、PCⅢ、LN含量小于血清含量,因此,临床仍采用血清测定肝纤维化4项标志物,但应重视血清HA含量低于正常值范围的肝纤维化待查者。 Objective To observe the test results of plasma and serum collagen type IV(CIV),hyaluronic acid(HA),procollagen typeIII(PCIII)and laminin(LN).Methods The 4 hepatic fibrosis markers in the serum and heparinized plasma samples of 56 healthy subjects were measured with radio-immunoassay,and the results were compared.Results The contents of CIV,PCIII and LN in serum were higher than those in plasma(P〈0.05),while the contents of HA in plasma were higher than those in serum(P〈0.05).The contents of CIV,HA and PCIII in plasma were correlated with those in serum(P〈0.001).However,the correlation was not observed in the contents of LN(P 0.05).Conclusion The 4 hepatic fibrosis markers can be measured in plasma,in which there are 3 markers correlated with the same ones in serum.Since the contents of CIV,PCIII and LN in plasma were lower than those in serum,and the 4 hepatic fibrosis markers must still be measured in serum for clinical practice.Great attention must be paid to the persons with serum HA contents lower than normal value ranges when they want to be examined for hepatic fibrosis.
出处 《检验医学与临床》 CAS 2010年第21期2349-2349,2351,共2页 Laboratory Medicine and Clinic
关键词 血清 血浆 肝纤维化标志物 serum plasma hepatic fibrosis markers
  • 相关文献

参考文献7

二级参考文献36

  • 1冯继红,王虹艳,刘波,季晓鹏.Ⅲ型前胶原、透明质酸在肝纤维化中的检测意义[J].大连医学院学报,1994,16(4):297-298. 被引量:1
  • 2钱绍诚.肝纤维化(肝硬化)的可逆性[J].中华消化杂志,1995,15(5):251-252. 被引量:134
  • 3陆伦根,曾民德.肝纤维化的诊断和评估[J].中华肝脏病杂志,2005,13(8):603-604. 被引量:100
  • 4[1]Lawrence DA. Transforming growth factor-β: An overview. Kidney Int, 1995,47: s-19-23.
  • 5[2]Barnard JA, Lyons RM, Moses HM. The cell biology of transforming growth factor β. Biotic Biopsy Acct,1990,1032:79-87.
  • 6[3]Bodes P, Parades V. Transforming growth factor-β: a key-role in liver fibrogenesis. J Hepatol, 1995,22 (Suppl. 2): 37-42.
  • 7[4]Asian RK, Sporran MB. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol,1986,102:1217-1223.
  • 8于兆佳,刘克辛.肝纤维化生化指标的测定及意义[J].大连医科大学学报,2007,29(4):396-399. 被引量:4
  • 9Vashist Y, Semela D, Dufour JF. Hyperdynamic circulation in liver cirrhosis: desensitization of vasoconstrictive receptors by G protein-coupled receptor kinases[J]. Med Hypotheses, 2004, 62(1): 82-85.
  • 10Yokomori H,Oda M,Ishii H. Improvement of overexpression of endothelin B receptor in human cirrhotic liver by interferon therapy[J]. J Gastroenterol, 2003, 38 (7): 707-709.

共引文献60

同被引文献36

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部